<p>The present invention generally relates to muscarinic receptor antagonists, which are useful in the treatment of various diseases of the respiratory, urinary or gastrointestinal systems mediated through muscarinic receptors. The invention also relates to processes for preparing such muscarinic receptor antagonists and pharmaceutical compositions thereof. The invention further relates to methods of treating diseases mediated through muscarinic receptors.</p>
